Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

H Gregg Alton


  • Chief Patient Officer at Gilead Sciences Inc (GILD), 2019-03-06
  • Director at Celladon Corp (CLDN), 2015-06-05
  • Director at Oculus Innovative Sciences Inc. (OCLS), 2012-10-02
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GILD $79.41 3,099 Officer 44,426 2018-03-01 Filing
GILD $78.92 16,200 Officer 47,525 2018-03-01 Filing
GILD $77.64 5,701 Officer 63,725 2018-03-01 Filing
GILD $81.54 14,435 Officer 0 2018-02-20 Filing
GILD $83.66 15,214 Officer 37,738 2018-02-01 Filing